Pradaxa 50 mg overtrukket granulat; forsyningsvanskelighed

Imported from official source

Announcement

Safety Classified by Officially

Markedsføringen af Pradaxa 50 mg overtrukket granulat fra Boehringer Ingelheim Danmark A/S vil ophøre.

Produkt: Pradaxa 50 mg overtrukket granulat

Aktivt stof: Dabigatranetexilat (Dabigatranetexilatmesilat)

Forventet periode: Fra slut november 2026

Virksomhed: Boehringer Ingelheim Danmark A/S

Yderligere information: Permanent markedsophør

This is an extract. The publication continues at the source.

Source: Lægemiddelstyrelsen.

Read the original at the source: https://laegemiddelstyrelsen.dk/da/godkendelse/kontrol-og-inspektion/mangel-paa-medicin/meddelelser-om-forsyning-af-medicin/human-2026/pradaxa-50-mg-overtrukket-granulat-forsyningsvanskelighed/

Officially imported this from Lægemiddelstyrelsen’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization
Lægemiddelstyrelsen — imported from official source
Official source
https://laegemiddelstyrelsen.dk/da/Feeds/rss-feed/ RSS
Imported
October 03, 2026 20:38
Versions
1 recorded
Identity
DB8D93542B2A4A7FA832848F53779B8A

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.